Page last updated: 2024-09-02

fr 139317 and pd 142893

fr 139317 has been researched along with pd 142893 in 1 studies

Study Comparison

Studies
(fr 139317)
Trials
(fr 139317)
Recent Studies (post-2010)
(fr 139317)
Studies
(pd 142893)
Trials
(pd 142893)
Recent Studies (post-2010)
(pd 142893)
219086403
219086403

Protein Interaction Comparison

ProteinTaxonomyfr 139317 (IC50)pd 142893 (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)4.4
Endothelin receptor type BRattus norvegicus (Norway rat)3.95
Endothelin receptor type BHomo sapiens (human)4.4
Endothelin-1 receptorHomo sapiens (human)4.1
Endothelin-1 receptorRattus norvegicus (Norway rat)4.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, XM; Cody, WL; Davis, LS; DePue, PL; Doherty, AM; Flynn, MA; He, JX; LaDouceur, DM; Reynolds, EE; Welch, KM1

Other Studies

1 other study(ies) available for fr 139317 and pd 142893

ArticleYear
In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 8

    Topics: Amino Acid Sequence; Animals; Arachidonic Acid; Azepines; Endothelin Receptor Antagonists; Endothelins; Ganglionic Blockers; Hemodynamics; In Vitro Techniques; Indoles; Male; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth, Vascular; Oligopeptides; Rabbits; Rats; Receptors, Endothelin; Structure-Activity Relationship; Vasoconstriction

1993